Ratifi Español Sign in
Ratifi

Federal bills from Congress.gov. State bills from Open States.

SB 1986Session 89R

What changed between versions

1 paragraph changed+1 word added−0 removed

Highlighted text was added in the newer version. Struck-through text was removed.

By: Hall, et al.

S.B. No. 1986

(VanDeaver)

A BILL TO BE ENTITLED

54 unchanged paragraphs

AN ACT

relating to warning labels for opioid prescription drugs.

BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:

SECTION 1. Section 481.074(a), Health and Safety Code, is

amended to read as follows:

(a) A pharmacist may not:

(1) dispense or deliver a controlled substance or

cause a controlled substance to be dispensed or delivered under the

pharmacist's direction or supervision except under a valid

prescription and in the course of professional practice;

(2) dispense a controlled substance if the pharmacist

knows or should have known that the prescription was issued without

a valid patient-practitioner relationship;

(3) fill a prescription that is not prepared or issued

as prescribed by this chapter;

(4) permit or allow a person who is not a licensed

pharmacist or pharmacist intern to dispense, distribute, or in any

other manner deliver a controlled substance even if under the

supervision of a pharmacist, except that after the pharmacist or

pharmacist intern has fulfilled his professional and legal

responsibilities, a nonpharmacist may complete the actual cash or

credit transaction and delivery; [ or ]

(5) permit the delivery of a controlled substance to

any person not known to the pharmacist, the pharmacist intern, or

the person authorized by the pharmacist to deliver the controlled

substance without first requiring identification of the person

taking possession of the controlled substance, except as provided

by Subsection (n) ; or

(6) dispense an opioid unless the bottle or container

in which the opioid is dispensed is affixed with a label warning of

the addictive nature of opioids and the risks of respiratory

depression and overdose as required by board rule under Section

481.0761(l) .

SECTION 2. Section 481.0761, Health and Safety Code, is

amended by adding Subsection (l) to read as follows:

(l) The board shall adopt rules requiring that an opioid be

dispensed in a bottle or container affixed with a label warning

users of the addictive nature of opioids and the risks of

respiratory depression and overdose. The label must include

language substantially similar to the following:

"CAUTION: Opioid. Risk of Addiction, Respiratory Depression,

and Overdose.".

SECTION 3. The Texas State Board of Pharmacy shall adopt the

rules required under Section 481.0761(l), Health and Safety Code,

as added by this Act, not later than January 1, 2026.

SECTION 4. The change in law made by this Act applies only

to a prescription for an opioid dispensed on or after March 1, 2026.

A prescription dispensed before March 1, 2026, is governed by the

law in effect immediately before the effective date of this Act, and

the former law is continued in effect for that purpose.

SECTION 5. This Act takes effect immediately if it receives

a vote of two-thirds of all the members elected to each house, as

provided by Section 39, Article III, Texas Constitution. If this

Act does not receive the vote necessary for immediate effect, this

Act takes effect September 1, 2025.

Back to the full text